These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2986349)

  • 1. Are hepatolithiasis and cholangiocarcinoma aetiologically related? A morphological study of 12 cases of hepatolithiasis associated with cholangiocarcinoma.
    Nakanuma Y; Terada T; Tanaka Y; Ohta G
    Virchows Arch A Pathol Anat Histopathol; 1985; 406(1):45-58. PubMed ID: 2986349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience of intrahepatic cholangiocarcinoma associated with hepatolithiasis.
    Ohta T; Nagakawa T; Konishi I; Ueno K; Kanno M; Akiyama T; Kayahara M; Izumi R; Konishi K; Miyazaki I
    Jpn J Surg; 1988 Jan; 18(1):47-53. PubMed ID: 2838667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatolithiasis associated with cholangiocarcinoma. Possible etiologic significance.
    Koga A; Ichimiya H; Yamaguchi K; Miyazaki K; Nakayama F
    Cancer; 1985 Jun; 55(12):2826-9. PubMed ID: 2986827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological features and interphase nucleolar organizer regions in hyperplastic, dysplastic and neoplastic epithelium of intrahepatic bile ducts in hepatolithiasis.
    Terada T; Nakanuma Y; Ohta T; Nagakawa T
    Histopathology; 1992 Sep; 21(3):233-40. PubMed ID: 1328014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal dysplasia of the liver and the intraductal variant of peripheral cholangiocarcinoma in hepatolithiasis.
    Ohta T; Nagakawa T; Ueda N; Nakamura T; Akiyama T; Ueno K; Miyazaki I
    Cancer; 1991 Nov; 68(10):2217-23. PubMed ID: 1655206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell kinetic analyses and expression of carcinoembryonic antigen, carbohydrate antigen 19-9 and DU-PAN-2 in hyperplastic, pre-neoplastic and neoplastic lesions of intrahepatic bile ducts in livers with hepatoliths.
    Terada T; Nakanuma Y
    Virchows Arch A Pathol Anat Histopathol; 1992; 420(4):327-35. PubMed ID: 1348889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholangiocarcinoma in hepatolithiasis.
    Chen PH; Lo HW; Wang CS; Tsai KR; Chen YC; Lin KY; Siauw CP; Hwang RR; Liu MH; Ko HC
    J Clin Gastroenterol; 1984 Dec; 6(6):539-47. PubMed ID: 6096441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferating cell nuclear antigen expression in peribiliary glands of stone-containing intrahepatic bile ducts.
    Lee KT; Sheen PC
    Dig Dis Sci; 1999 Nov; 44(11):2251-6. PubMed ID: 10573370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology of hepatolithiasis: cholangitis and cholangiocarcinoma.
    Ohta G; Nakanuma Y; Terada T
    Prog Clin Biol Res; 1984; 152():91-113. PubMed ID: 6089228
    [No Abstract]   [Full Text] [Related]  

  • 10. Late development of cholangiocarcinoma after the treatment of hepatolithiasis.
    Chijiiwa K; Ichimiya H; Kuroki S; Koga A; Nakayama F
    Surg Gynecol Obstet; 1993 Sep; 177(3):279-82. PubMed ID: 8395085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein expression of double-stranded RNA-activated protein kinase (PKR) in intrahepatic bile ducts in normal adult livers, fetal livers, primary biliary cirrhosis, hepatolithiasis and intrahepatic cholangiocarcinoma.
    Terada T; Ueyama J; Ukita Y; Ohta T
    Liver; 2000 Dec; 20(6):450-7. PubMed ID: 11169059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the impact of coexistence of hepatolithiasis on cholangiocarcinoma?
    Lee CC; Wu CY; Chen GH
    J Gastroenterol Hepatol; 2002 Sep; 17(9):1015-20. PubMed ID: 12167124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The assessment of biliary CA 125, CA 19-9 and CEA in diagnosing cholangiocarcinoma--the influence of sampling time and hepatolithiasis.
    Chen CY; Shiesh SC; Tsao HC; Lin XZ
    Hepatogastroenterology; 2002; 49(45):616-20. PubMed ID: 12063953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal type cholangiocarcinoma of intrahepatic large bile duct associated with hepatolithiasis--a new histologic subtype for further investigation.
    Bae JY; Park YN; Nakanuma Y; Lee WJ; Kim JY; Park C
    Hepatogastroenterology; 2002; 49(45):628-30. PubMed ID: 12063956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholangiocarcinoma as related to chronic intrahepatic cholangitis and hepatolithiasis. Case report and review of the literature.
    Falchuk KR; Lesser PB; Galdabini JJ; Isselbacher KJ
    Am J Gastroenterol; 1976 Jul; 66(1):57-61. PubMed ID: 184709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoembryonic antigen and blood group-related carbohydrate antigens in glycoproteins in human bile in hepatolithiasis. Japanese Study Group of Hepatolithiasis.
    Sasaki M; Morita T; Hoso M; Nakanuma Y; Tanimura H
    Hepatology; 1996 Feb; 23(2):258-63. PubMed ID: 8591850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reappraisal of cholangiocarcinoma in patient with hepatolithiasis.
    Chen MF; Jan YY; Wang CS; Hwang TL; Jeng LB; Chen SC; Chen TJ
    Cancer; 1993 Apr; 71(8):2461-5. PubMed ID: 8384069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors predicting concurrent cholangiocarcinomas associated with hepatolithiasis.
    Kim YT; Byun JS; Kim J; Jang YH; Lee WJ; Ryu JK; Kim SW; Yoon YB; Kim CY
    Hepatogastroenterology; 2003; 50(49):8-12. PubMed ID: 12629979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of carcinoembryonic antigen related to biliary malignancy in hepatolithiasis.
    Ker CG; Sheen PC; Chien CH; Wu CC
    Surg Today; 1993; 23(6):496-9. PubMed ID: 8358193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahepatic cholangiocarcinoma in hepatolithiasis: A frequently overlooked disease.
    Sheen-Chen SM; Chou FF; Eng HL
    J Surg Oncol; 1991 Jun; 47(2):131-5. PubMed ID: 1648151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.